LN PHARMA CONSULTING

Seraing ·KBO/BCE: BE 0751.561.740

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	18-11-2025	110 d late	2025-00568146
31-12-2023	31-07-2024	28-06-2024	33 d early	2024-00184373
31-12-2022	31-07-2023	30-06-2023	31 d early	2023-00194601
31-12-2021	31-07-2022	29-07-2022	2 d early	2022-20253874

Metric	This company	Sector median	Position in the sector
Solvency	10.5%	20.4%	better than 39% of 6722 sector peers
Net result	€49k	€4k	better than 89% of 6703 sector peers
Equity	€9k	€16k	better than 41% of 6737 sector peers
Gross operating margin	€64k	€24k	better than 72% of 6682 sector peers
Total assets	€88k	€94k	better than 48% of 6726 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€88k
Current assets	29/58	€88k
Amounts receivable within one year	40/41	€62k
Cash & bank	54/58	€15k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€88k
Equity	10/15	€9k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€4k
Amounts payable	17/49	€78k
Amounts payable within one year	42/48	€78k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€64k
Operating result	9901	€62k
Financial income	75	€3k
Financial charges	65	€330
Result before taxes	9903	€65k
Income taxes	67/77	€16k
Net result for the period	9904	€49k
Result to be appropriated	9905	€49k

Summary